Vivos Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -0.258 | -100% |
| P/S |
|
0.9949 | 33.75 | -97.05% |
|
|
| P/BV |
|
33.41 | 4.82 | 593.44% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.8445 | -22.17 | -96.19% |
|
|
| Ev/S |
|
1.02 | 22.56 | -95.48% |
|
|
| Ev/FCF |
|
-1.1 | 68.75 | -101.6% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-120.82 | 4.98 | -2527.69% | -111.06 | +8.79% |
| ROE |
|
-3304.87 | 9.61 | -34484.2% |
|
|
| ROA |
|
-126.59 | 0.3443 | -36871.4% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-98.42 | -25.17 | 291.02% |
|
|
| ROCE |
|
-4208.27 | 15.35 | -27514.85% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1196 | -3.68 | -96.75% | -0.1091 | +9.65% |
| Nеt Debt/Ebitda |
|
-0.0211 | -3.44 | -99.39% |
|
|
| Debt/Ratio |
|
0.1859 | 0.1985 | -6.33% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.1469 | 10.32 | -101.42% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
21.06 | -56.89 | -137.02% | ||
| Growth impulse Ebitda in 5 years |
|
70.15 | -54.68 | -228.29% | ||
| Growth impulse Net Income in 5 years |
|
24.61 | -58.33 | -142.19% | ||
| Growth impulse FCF in 5 years |
|
132.71 | -49.48 | -368.21% | ||
| Growth impulse EPS in 5 years |
|
1706.85 | -32.41 | -5366.43% |
IP Score
4.44/10
